Biocomposites opens new sales and distribution office in Italy
18 Jan 2024
Drug Approval
Biocomposites, an international medical devices company that engineers, manufactures and market products for use in infection management in bone and soft tissue, is opening its new sales and distribution office, and incorporation of Biocomposites SRL, in Italy to support the sale of its STIMULAN, NanoBone, genex and SYNICEM Spacer products.
STIMULAN, the only calcium sulphate antibiotic carrier to be approved for use in bone and soft tissue, is already an important tool used by Italian surgeons to help them manage their infection cases. The opening of a new sales and distribution office in Prato, near Florence, along with the recruitment of a team of specialists to promote and support the use of the products, will deliver a more direct relationship between Biocomposites and its customers in the country.
Led by Pierluigi Leone, general manager, the sales team will continue to work with local agents to fulfil tenders and introduce the broader Biocomposites portfolio to surgeons and hospitals throughout Italy.
Leone said: “This is an exciting time for Biocomposites Italy. We have established an experienced team, incorporated Biocomposites SRL, and set up our new distribution centre in only a few months. We formally opened the office at the beginning of the year and are already providing surgeons with our unique products. I look forward to developing and expanding our team.”
Michael Harris, chief executive officer of Biocomposites, said: “Strengthening our Italian operation is part of Biocomposites’ successful strategy of growing the company by expanding its presence in markets across the world.
“With our comprehensive portfolio of products for use in bone and soft tissue available in Italy, it was an important next step for us to open a sales and distribution office to support our customers there. Over the coming months, I look forward to seeing these products helping more surgeons and their patients.”
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.